Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.49 USD | -4.03% | +5.48% | -34.03% |
28/06 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
28/06 | Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.03% | 479.27Cr | |
+8.22% | 10TCr | |
+11.97% | 4.39TCr | |
-11.76% | 3.32TCr | |
+79.34% | 2.94TCr | |
-12.20% | 1.61TCr | |
+4.00% | 1.47TCr | |
-1.90% | 1.29TCr | |
+178.17% | 1.05TCr | |
+1.80% | 882.97Cr |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Transcript : Apellis Pharmaceuticals, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 08